Early Research Suggests a Path to Predict and Prevent Lung Cancer

Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the ...

New breakthrough in developing more personalized treatments for lung cancer

A study by the University of Barcelona has discovered why the two main types of lung cancer—adenocarcinoma of the lung and ...
MarketBeat on MSN

Black Diamond Therapeutics touts Silevertinib lung cancer data, eyes FDA path

Key Points Interested in Black Diamond Therapeutics, Inc.? Here are five stocks we like better. Silevertinib showed ...
Medical Xpress

Despite breakthroughs, many go without treatment for metastatic lung cancer

About half of people diagnosed with metastatic non-small-cell lung cancer never receive treatment, despite advances in options over recent decades that have created meaningful improvements in lifespan ...
ascopubs.org

The frequency of driver mutations in non-small cell lung cancer patients: The Turkish nation-wide, observational, Registurk-Lung study (updated analysis).

A global phase 2/3, randomized, open-label trial of BNT327/PM8002 in combination with chemotherapy (chemo) in first-line (1L) non-small cell lung cancer (NSCLC). This is an ASCO Meeting Abstract from ...